Hikma Pharmaceuticals PLC (HIK)
Last update: 20 November 2007 01:44 PM market time.
-1.25
-6.11%
Open
19.90
Previous Close
20.45
High
19.90
Low
19.20
Stock Statistics
Volume
200
Turnover
3,910.00
All data are 15 minutes late during market session
- Stock
- Company Profile
- News
- Announcements
- Fair Values
- Corporate Actions
- Earning Announcements
- News Reports
- Volume Statistics
- Financial Ratios
- IPOs
- Financial Statements
- Support and resistance
- More
General Information
Company Name
Hikma Pharmaceuticals PLC (HIK)
Company Purpose
Hikma Pharmaceuticals PLC is engaged in the development, manufacture and marketing of a broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.
Company Establish Date
01 January 1978
Financial Year Start
Auditor
- PricewaterhouseCoopers LLP - United Kingdom
Ownership
- Darhold Ltd (26.40%)
- Capital Research and Management Co (10.9921%)
- Capita Group International (10.10%)
- Fidelity International (4.10%)
- Mazen Darwazah (0.5611%)
- Ali Al Husry (0.4845%)
- Said Darwazah (0.4746%)
Management
Said Samih Taleb Darwazah
Chairman
Pamela Kirby
Board Members
Cynthia Schwalm
Board Members
Sigurdur Siggi Olafsson
Board Members
Patrick Butler
Board Members
Nina Henderson
Board Members
Robert Pickering
Board Members
Ronald Goode
Board Members
Ali Al Husry
Board Members
Mazen Samih Taleb Darwazah
Board Members
Douglas Hurt
Board Members
Subsidiaries
- Hikma Mena Holdings Ltd (100.00%)
- Hikma Finance Luxembourg SARL (100.00%)
- Eurohealth International SARL (100.00%)
- Hikma International NV (100.00%)
- AMKI Mena Holdings (100.00%)
- Hikma Acquisitions Ltd (100.00%)
- Hikma Ltd (100.00%)
- Hikma Pharma Ltd (100.00%)
- Jazeera Pharmaceutical Industries (52.50%)
Contacts
Address
1 New Burlington Place, London W1S 2HR
Phone
+44 2073992760
Fax
+44 2073992761
Website
www.hikma.com
Email
investors@hikma.uk.com
Contact Person
Hana Darwazah Ramadan